Cargando…
Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer
Brain metastasis (BM) is rare in colorectal cancer (CRC) patients. Although BM from CRC is a late-stage phenomenon with an extremely poor prognosis, some subsets of patients would benefit from a multidisciplinary management strategy. The prognosis of patients with BM from CRC was associated with the...
Autores principales: | Yoshida, Yoichiro, Hoshino, Seiichiro, Aisu, Naoya, Naito, Masayasu, Tanimura, Syu, Sasaki, Takamitsu, Takeno, Shinsuke, Yamashita, Yuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975757/ https://www.ncbi.nlm.nih.gov/pubmed/24707258 http://dx.doi.org/10.1159/000360132 |
Ejemplares similares
-
A Report of Disseminated Carcinomatosis of the Bone Marrow Originating from Transverse Colon Cancer Successfully Treated with Chemotherapy Using XELOX plus Bevacizumab
por: Naito, Masayasu, et al.
Publicado: (2014) -
A Successfully Resected Case of Recurrent Lung and Liver Metastases of Rectal Cancer Treated with XELIRI + Bevacizumab Therapy
por: Aisu, Naoya, et al.
Publicado: (2013) -
Early Start of Chemotherapy after Resection of Brain Metastasis from Colon Cancer with Synchronous Multiple Liver Metastases
por: Yoshida, Yoichiro, et al.
Publicado: (2012) -
Pilot study of the early start of chemotherapy after resection of primary colorectal cancer with distant metastases (Pearl Star 01)
por: Yoshida, Yoichiro, et al.
Publicado: (2013) -
Desmoplastic Small Round Cell Tumor: Report of 2 Cases Treated with Chemotherapy Alone or in Combination with Bevacizumab
por: de Araújo, Rogério Agenor, et al.
Publicado: (2014)